ARTICLE | Company News
Korea approves Green Cross' Hunterase
February 10, 2012 1:19 AM UTC
Green Cross Corp. (Yongin-si, South Korea) said Korea's FDA approved Hunterase to treat Hunter syndrome (mucopolysaccharidosis II). Hunterase is a recombinant iduronate-2-sulfatase (IDS). ...